- Locations
- Phone
About Me
I am a board-certified neuroradiologist. My primary interest is pediatric brain tumor imaging. My responsibilities involve reading MRI and CT scans of both adults and children to diagnose cancer in the brain and spine. I also read these images to see if tumor is responding to therapy, and to identify any potential complications of cancer or its treatment. I also perform diagnostic procedures such as lumbar punctures. They can help surgeons and medical oncologists manage the care of people with cancer that has spread or those who have primary brain tumors, leukemia, and lymphoma.
I have a passion for theranostic research. This involves using imaging not only to diagnose cancer but also to evaluate treatment. I am also involved in research to see how well combined chemotherapy treatments work for metastatic breast cancer as well as head and neck cancer. In addition, I participate in efforts to develop new antibody therapies for pediatric brain tumors, such as pontine gliomas, neuroblastomas, and medulloblastomas. I have a particular focus on retinoblastoma, a rare pediatric cancer. I am developing new and advanced techniques that can be especially helpful for evaluating tumors that have been historically hard to treat. I am a member of the Pediatric Neuro-Oncologic Disease Management Team. We integrate the latest advances in medicine, surgery, and diagnostic imaging in patient care and research. For example, I helped develop whole-body MRI screening protocols in people with a known genetic susceptibility due to Li-Fraumeni syndrome and nevoid basal cell carcinoma syndrome. I am also a member of the Brain Tumor Center, the Pediatric Brain Tumor Consortium, and the Children’s Oncology Group. I oversee the training and education of fellows in neuroradiology. I am excited to participate in their education daily.
See My Colleagues
Publications
Haque SS. Imaging of Lymphoma of the Central Nervous System, Spine, and Orbit. MRI Clinics of North America. February 2010.
Matthew G. Fury, Sofia Haque, Hilda Stambuk, Ronglai Shen, Diane Carlson, David Pfister. A Phase II Study of Pemetrexed Plus Gemcitabine Every Two Weeks for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC) Haque Sofia, MD “Imaging of Lymphoma of the Central Nervous System, Spine, and Orbit,” Radiologic Clinics of North America. February 2010. Haque Sofia, MD Douglas E. Ney, MD, Jason T. Huse, MD, Ira J. Dunkel, MD, Peter G. Steinherz, MD, Yasmin Khakoo, MD. Intraventricular Meningioma after Cranial Irradiation for Childhood Leukemia. September 2009. Young RJ, Haque SS, Lyo J. Toxic and Metabolic Diseases. In: Law M, Naidich TP, Som P, eds. Problem Solving in Neuroradiology Philadelphia, PA: Elsevier 2009.
Clinical Trials
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.
Learn moreInsurance
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicare and New York State Medicaid also provide benefits for care at MSK.
Learn more